产品编号 :
Cas No. :
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 50mg | 98% | 询价 | |||
| 100mg | 98% | 询价 | |||
| 250mg | 98% | 询价 | |||
| 1g | 98% | 询价 |
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 50mg | 98% | 询价 | |||
| 100mg | 98% | 询价 | |||
| 250mg | 98% | 询价 | |||
| 1g | 98% | 询价 |
CAS No. |
2170118-23-5 |
|---|---|
中文名称 |
(S)-4-[(4,11-二乙基-9-羟基-3,14-二氧代-3,4,12,14-四氢-1H-吡喃并[3',4':6,7]吲哚并[1,2-b]喹啉-4-基)氧基]-4-氧代丁酸 |
英文名称 |
(S)-4-((4,11-Diethyl-9-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-4-yl)oxy)-4-oxobutanoic acid |
别名 |
Butanedioic acid, 1-[(4S)-4,11-diethyl-3,4,12,14-tetrahydro-9-hydroxy-3,14-dioxo-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-4-yl] ester;SN38-COOH;(S)-4-((4,11-Diethyl-9-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-4-yl)oxy)-4-oxobutanoic acid |
标准英文名 |
(S)-4-((4,11-diethyl-9-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-4-yl)oxy)-4-oxobutanoic acid |
MDL No. |
MFCD35244936 |
分子式 |
C26H24N2O8 |
分子量 |
492.48 |
精确分子量 |
492.15 |
SMILES |
O=C(O)CCC(O[C@](C1=C(CO2)C(N3CC4=C(CC)C5=CC(O)=CC=C5N=C4C3=C1)=O)(CC)C2=O)=O |
标准SMILES |
CC[C@]1(OC(=O)CCC(O)=O)C2C=C3C4=NC5=CC=C(O)C=C5C(CC)=C4CN3C(=O)C=2COC1=O |
性状 |
Powder or crystals |
用途 |
For laboratory research purposes. Not for drug or household use. |
信号词 |
Danger |
InChIKey |
AOWPNVSSWGMHGV-SANMLTNESA-N |
危险类别(旧) |
H301,H311,H331 |
存储要求 |
Keep in dark place, Inert atmosphere, Store in freezer, under - 20°C,Keep container tightly closed in a dry and well-ventilated area. Containers which are opened must be carefully resealed and kept upright to prevent leakage. |
危险品分类 |
Acute toxicity, oral (Category 3),Acute toxicity, dermal (Category 3),Acute toxicity, inhalation (Category 3) |
|---|---|
UN No. |
2811,2811,2811 |
化学稳定性 |
Stable under recommended storage conditions. |
符号 |
|
|
|
评论 |
|---|